ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,807, issued on June 17, was assigned to MegaNano Biotech Inc. (Tampa, Fla.).
"Dead antigen stimulated immature heterogenous dendritic cells as therapeutics for diseases" was invented by Chuanhai Cao (Tampa, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are exogenous antigen sensitized immature dendritic cells. The dendritic cell may also be dead. The exogenous antigen sensitized immature dendritic cells may be used to elicit an increased immune response. Further provided are vaccines comprising the exogenous antigen sensitized immature dendritic cells, methods, of inducing an immune response in a patient, and methods of treati...